NORTH AMERICA BIOSURGERY MARKET 2021-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	167 Pages	Triton Market Research	July, 2021	TRTN16847605

Best Price Guarantee
Price	from $1,500
Length	167 Pages
Publisher	Triton Market Research
Published Date	July, 2021
SKU	TRTN16847605

NORTH AMERICA BIOSURGERY MARKET 2021-2028

MARKET OUTLOOK

As per Triton’s research report, the biosurgery market in North America is predicted to display a compound annual growth rate of 5.30% in the years 2021-2028. The United States and Canada form the market in this region.

According to the Canadian Institute for Health Information, in the past few years, there has been a significant rise in knee replacement surgeries, fractures, coronary artery angioplasties, and hip replacement therapy across Canada. These statistics suggest the demand for biosurgery products is likely to gain momentum within the next few years. Additionally, heart disease is considered to be the second leading cause of death after cancer that has enhanced the requirement for surgical procedures for cardiac patients. Therefore, the rising surgical procedures will fuel the demand for Biosurgical products, driving the biosurgery market on a growth path across Canada.

In the United States, the older population base is estimated to grow significantly by 2060, which will increase the number of surgeries. Hence, the rise in the geriatric population, coupled with new product launches, is likely to create new opportunities for the biosurgery market over the next few years. Besides, the introduction of new products will boost the studied market’s progress across the country. For instance, in January 2020, OrthoPediatrics Corp, launched a completely synthetic bone graft substitute featuring calcium phosphate cement that imitates the mineral phase of natural bone.

COMPETITIVE OUTLOOK

The well-known companies in the biosurgery market are B Braun Melsungen AG, Stryker Corporation, Integra Lifesciences Holdings Corporation, Sanofi, Ethicon Inc (Johnson & Johnson), and Zimmer Biomet Holdings Inc.

1. NORTH AMERICA BIOSURGERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK: 2.1. IMPACT OF COVID-19 ON BIOSURGERY MARKET; 2.2. TRENDS IN BIOSURGERY TECHNOLOGY; 2.3. KEY INSIGHTS; 2.4. PORTER’S FIVE FORCES MODEL; 2.4.1. THREAT OF NEW ENTRANTS; 2.4.2. THREAT OF SUBSTITUTE PRODUCTS; 2.4.3. BARGAINING POWER OF BUYERS; 2.4.4. BARGAINING POWER OF SUPPLIERS; 2.4.5. COMPETITIVE RIVALRY; 2.5. MARKET ATTRACTIVENESS INDEX; 2.6. VENDOR SCORECARD; 2.7. KEY BUYING OUTLOOK; 2.8. KEY MARKET STRATEGIES; 2.8.1. CONTRACTS AND PARTNERSHIPS; 2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES; 2.8.3. ACQUISITIONS & MERGERS; 2.8.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS; 2.9. MARKET DRIVERS; 2.9.1. GROWING AGING POPULATION; 2.9.2. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN HEALTHCARE FACILITIES; 2.9.3. SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS; 2.9.4. PREVALENCE OF SPINAL FUSION AND JOINT RECONSTRUCTION; 2.9.5. STRONG FOCUS ON RESEARCH AND DEVELOPMENT; 2.10. MARKET CHALLENGES; 2.10.1. HIGH COST OF SURGERIES; 2.10.2. COMPLICATIONS RELATED TO IMMUNE RESPONSE; 2.10.3. USAGE OF MINIMALLY INVASIVE SURGERIES; 2.11. MARKET OPPORTUNITIES; 2.11.1. RESEARCH AND INVESTMENTS IN BIOENGINEERING; 2.11.2. DEVELOPMENT OF POLICIES FOR REIMBURSEMENT AND COMPENSATION
3. NORTH AMERICA BIOSURGERY MARKET – BY PRODUCT: 3.1. HEMOSTATIC AGENTS; 3.2. BONE-GRAFT SUBSTITUTES; 3.2.1. SYNTHETIC GRAFT EXTENDERS; 3.2.2. DEMINERALIZED BONE MATRIX; 3.2.3. BONE MORPHOGENETIC PROTEINS; 3.2.4. CELL-BASED MATRICES; 3.3. SURGICAL SEALING AGENTS; 3.3.1. NATURAL; 3.3.2. SYNTHETIC; 3.4. SOFT-TISSUE MANAGEMENT; 3.4.1. SYNTHETIC MESH/PATCH; 3.4.2. NATURAL MESH/PATCH; 3.5. ANTI-ADHESIVE AGENTS; 3.6. STAPLE LINE REINFORCEMENT
4. NORTH AMERICA BIOSURGERY MARKET – BY APPLICATION: 4.1. ORTHOPEDIC SURGERY; 4.2. CARDIO AND THORACIC SURGERY; 4.3. NEURO AND SPINE SURGERY; 4.4. GENERAL SURGERY; 4.5. OTHER APPLICATIONS
5. NORTH AMERICA BIOSURGERY MARKET – BY SOURCE TYPE: 5.1. NATURAL; 5.2. SYNTHETIC
6. NORTH AMERICA BIOSURGERY MARKET – COUNTRY OUTLOOK: 6.1. COUNTRY ANALYSIS; 6.1.1. UNITED STATES; 6.1.2. CANADA
7. COMPETITIVE LANDSCAPE: 7.1. BAXTER INTERNATIONAL INC; 7.2. BECTON, DICKINSON AND COMPANY; 7.3. B BRAUN MELSUNGEN AG; 7.4. CSL LIMITED; 7.5. ETHICON INC (JOHNSON & JOHNSON); 7.6. INTEGRA LIFESCIENCES HOLDINGS CORPORATION; 7.7. MEDTRONIC PLC; 7.8. RTI SURGICAL; 7.9. SANOFI; 7.10. SMITH & NEPHEW PLC; 7.11. STRYKER CORPORATION; 7.12. WRIGHT MEDICAL GROUP NV; 7.13. ZIMMER BIOMET HOLDINGS INC
8. RESEARCH METHODOLOGY & SCOPE: 8.1. RESEARCH SCOPE & DELIVERABLES; 8.1.1. OBJECTIVES OF STUDY; 8.1.2. SCOPE OF STUDY; 8.2. SOURCES OF DATA; 8.2.1. PRIMARY DATA SOURCES; 8.2.2. SECONDARY DATA SOURCES; 8.3. RESEARCH METHODOLOGY; 8.3.1. EVALUATION OF PROPOSED MARKET; 8.3.2. IDENTIFICATION OF DATA SOURCES; 8.3.3. ASSESSMENT OF MARKET DETERMINANTS; 8.3.4. DATA COLLECTION; 8.3.5. DATA VALIDATION & ANALYSIS; LIST OF TABLES; TABLE 1: NORTH AMERICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION); TABLE 2: VENDOR SCORECARD; TABLE 3: CONTRACTS AND PARTNERSHIPS; TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES; TABLE 5: ACQUISITIONS & MERGERS; TABLE 6: NEW PRODUCT LAUNCHES & DEVELOPMENTS; TABLE 7: NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION); TABLE 8: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 9: NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 10: NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 11: NORTH AMERICA BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION); TABLE 12: NORTH AMERICA BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION); TABLE 13: NORTH AMERICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION); LIST OF FIGURES; FIGURE 1: NORTH AMERICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION); FIGURE 2: NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN %); FIGURE 3: NORTH AMERICA BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION); FIGURE 4: NORTH AMERICA BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION); FIGURE 5: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION); FIGURE 6: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION); FIGURE 7: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION); FIGURE 8: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION); FIGURE 9: NORTH AMERICA BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION); FIGURE 10: NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION); FIGURE 11: NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION); FIGURE 12: NORTH AMERICA BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION); FIGURE 13: NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION); FIGURE 14: NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION); FIGURE 15: NORTH AMERICA BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION); FIGURE 16: NORTH AMERICA BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION); FIGURE 17: NORTH AMERICA BIOSURGERY MARKET, BY APPLICATION, 2020 & 2028 (IN %); FIGURE 18: NORTH AMERICA BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION); FIGURE 19: NORTH AMERICA BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION); FIGURE 20: NORTH AMERICA BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION); FIGURE 21: NORTH AMERICA BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION); FIGURE 22: NORTH AMERICA BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION); FIGURE 23: NORTH AMERICA BIOSURGERY MARKET, BY SOURCE TYPE, 2020 & 2028 (IN %); FIGURE 24: NORTH AMERICA BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION); FIGURE 25: NORTH AMERICA BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION); FIGURE 26: UNITED STATES BIOSURGERY MARKET 2021-2028 (IN $ MILLION); FIGURE 27: CANADA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)